Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1793800rdf:typepubmed:Citationlld:pubmed
pubmed-article:1793800lifeskim:mentionsumls-concept:C0010194lld:lifeskim
pubmed-article:1793800lifeskim:mentionsumls-concept:C0018593lld:lifeskim
pubmed-article:1793800lifeskim:mentionsumls-concept:C0220781lld:lifeskim
pubmed-article:1793800lifeskim:mentionsumls-concept:C1527148lld:lifeskim
pubmed-article:1793800lifeskim:mentionsumls-concept:C0870883lld:lifeskim
pubmed-article:1793800lifeskim:mentionsumls-concept:C1883254lld:lifeskim
pubmed-article:1793800lifeskim:mentionsumls-concept:C0020980lld:lifeskim
pubmed-article:1793800lifeskim:mentionsumls-concept:C0205164lld:lifeskim
pubmed-article:1793800lifeskim:mentionsumls-concept:C1873127lld:lifeskim
pubmed-article:1793800pubmed:issue5lld:pubmed
pubmed-article:1793800pubmed:dateCreated1992-4-6lld:pubmed
pubmed-article:1793800pubmed:abstractText4-Carboxyl-substituted analogues of trans-3'-hydroxycotinine were synthesized to be covalently linked to macromolecules for antibody production. 3-Pyridyl-N-methylnitrone was condensed with dimethyl fumarate to give two isomeric isoxazolidines. Hydrogenolysis of the major product [2RS-(2 alpha,3 alpha,3 beta)]-3-carbomethoxy-3- [[(benzyloxy)carbonyl]oxy]-1-methyl-5-oxo-2-(3-pyridinyl)pyrrolidine with Pd/C followed by hydrolysis gave [2RS-(2 alpha,3 beta,4 beta)]-4-hydroxy-1-methyl-5-oxo-2-(3-pyridinyl)-3- pyrrolidinecarboxylic acid. The same compound was also prepared in two steps in high yield starting with dibenzyl fumarate and 3-pyridyl-N-methylnitrone.lld:pubmed
pubmed-article:1793800pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1793800pubmed:languageenglld:pubmed
pubmed-article:1793800pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1793800pubmed:citationSubsetIMlld:pubmed
pubmed-article:1793800pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1793800pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1793800pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1793800pubmed:statusMEDLINElld:pubmed
pubmed-article:1793800pubmed:issn0893-228Xlld:pubmed
pubmed-article:1793800pubmed:authorpubmed-author:AminSSlld:pubmed
pubmed-article:1793800pubmed:authorpubmed-author:DesaiD HDHlld:pubmed
pubmed-article:1793800pubmed:issnTypePrintlld:pubmed
pubmed-article:1793800pubmed:volume4lld:pubmed
pubmed-article:1793800pubmed:ownerNLMlld:pubmed
pubmed-article:1793800pubmed:authorsCompleteYlld:pubmed
pubmed-article:1793800pubmed:pagination524-7lld:pubmed
pubmed-article:1793800pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:1793800pubmed:meshHeadingpubmed-meshheading:1793800-...lld:pubmed
pubmed-article:1793800pubmed:meshHeadingpubmed-meshheading:1793800-...lld:pubmed
pubmed-article:1793800pubmed:meshHeadingpubmed-meshheading:1793800-...lld:pubmed
pubmed-article:1793800pubmed:meshHeadingpubmed-meshheading:1793800-...lld:pubmed
pubmed-article:1793800pubmed:meshHeadingpubmed-meshheading:1793800-...lld:pubmed
pubmed-article:1793800pubmed:articleTitleSynthesis of a hapten to be used in development of immunoassays for trans-3'-hydroxycotinine, a major metabolite of cotinine.lld:pubmed
pubmed-article:1793800pubmed:affiliationDivision of Chemical Carcinogenesis, Naylor Dana Institute for Disease Prevention, American Health Foundation, Valhalla, New York 10595.lld:pubmed
pubmed-article:1793800pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1793800pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed